Literature DB >> 1358191

Most residues on the floor of the antigen binding site of the class I MHC molecule H-2Kd influence peptide presentation.

C Jaulin1, P Romero, I F Luescher, J L Casanova, A Prochnicka-Chalufour, P Langlade-Demoyen, J L Maryanski, P Kourilsky.   

Abstract

A panel of 15 single alanine substitutions on the floor of the peptide binding groove of the murine class I histocompatibility molecule H-2Kd has been analyzed. All but two mutant molecules were expressed on the cell surface, and were tested for peptide binding and presentation to specific cytotoxic T lymphocytes. Eleven out of 13 mutant molecules appeared to be functionally altered. Five of the substituted residues were involved in the presentation of all peptides tested. Three participated in the presentation of certain peptides but not others. Three other residues participated in epitope formation through indirect interactions. Only two mutations had no detectable effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358191     DOI: 10.1093/intimm/4.8.945

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

1.  Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus.

Authors:  C E Hioe; D M McKinney; J A Frelinger; M McMillan
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

2.  Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.

Authors:  Landon G Vom Steeg; Yevel Flores-Garcia; Fidel Zavala; Sabra L Klein
Journal:  Vaccine       Date:  2019-06-28       Impact factor: 3.641

3.  Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic.

Authors:  E Mottez; P Langlade-Demoyen; H Gournier; F Martinon; J Maryanski; P Kourilsky; J P Abastado
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.